William W. Jia
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology.
Journal: Nature reviews. Clinical oncology
Published: August 10, 2026
Radiotherapy Enhances the Oncolytic Efficacy of the Novel Oncolytic Herpesvirus VG161 and Amplifies Its Antitumor Immunity in Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 17, 2025
Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma.
Journal: Nature
Published: April 24, 2025
An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Naïve/Primed Murine Models.
Journal: Vaccines
Published: February 10, 2025
Heterologous prime-boost with an mRNA vaccine and an oncolytic virus enhances tumor regression through overcoming intratumoral immune suppression.
Journal: Cell reports
Published: September 23, 2024
Oncolytic virus VG161 in refractory hepatocellular carcinoma.
Journal: Nature
Published: June 19, 2024
Efficacy and safety of YOXINTINE for depression: A double-blinded, randomized, placebo-controlled, phase 2 clinical trial.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 21, 2024
A Novel Self-Amplifying mRNA with Decreased Cytotoxicity and Enhanced Protein Expression by Macrodomain Mutations.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 20, 2024
Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases.
Journal: Oncology letters
Published: October 18, 2023
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells.
Journal: Vaccines
Published: September 27, 2023
Last Updated: 09/26/2026